News

Expands the reach of the Group’s integrated drug discovery and development services in the US.

Scientists identify new molecular target linked to alcohol addiction

The risk of preterm infants developing necrotizing enterocolitis (NEC) is higher when they are fed formula than when they feed on breast milk. A new study reports an association between the type of carbohydrates in formula, the products of metabolism or metabolites, and the risk of NEC in a piglet model of the human condition.

Scientists studied inflammation and rehabilitation training in rodents and discovered that creating a mild inflammatory response improved a rat’s ability to relearn how to pick up pellets months following a spinal cord injury.

Healthcare to become standalone company; GE expects to monetize 20% and distribute remaining 80% of GE Healthcare to shareholders tax-free.

New collaborative project in Wisconsin makes breathtaking light sheet imagery more accessible

Scientists led by Daigo Shoji from the Earth-Life Science Institute (Tokyo Institute of Technology) have shown that an artificial intelligence program called a Convolutional Neural Network can be trained to categorize volcanic ash particle shapes. Because the shapes of volcanic particles are linked to the type of volcanic eruption, this categorization can help provide information on eruptions and aid volcanic hazard mitigation efforts.

A genetically modified poliovirus therapy developed at Duke Cancer Institute shows significantly improved long-term survival for patients with recurrent glioblastoma, with a three-year survival rate of 21% in a phase 1 clinical trial. Comparatively, just 4% of patients at Duke with the same type of recurring brain tumors were alive at three years when undergoing the previously available standard treatment.

New research demonstrates that the Na/K-ATPase oxidant amplification loop (NAKL) is intimately involved in the aging process and may serve as a target for anti-aging interventions.

A genetic anomaly in certain men with prostate cancer may impact their response to common drugs used to treat the disease according to new research. The findings may provide important information for identifying which patients potentially fare better when treated with an alternate therapy.